Evidence map›Paper›PMID 42529759›Full record

ArticleEJHaem2026

The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes.

Dominic Culligan, Adele Taylor, Alexandra Smith, Catherine Cargo, Howard Oster, Argiris Symeonidis, Reinhard Stauder, Saskia Langemeijer, Luca Malcovati, Pierre Fenaux and 10 more

Abstract read
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Dominic CulliganDepartment of Haematology Aberdeen Royal Infirmary Aberdeen UK.ORCID https://orcid.org/0009-0003-9209-0903
Adele TaylorEpidemiology and Cancer Statistics Group, Department of Health Sciences University of York York UK.ORCID https://orcid.org/0000-0001-7793-8222
Alexandra SmithEpidemiology and Cancer Statistics Group, Department of Health Sciences University of York York UK.ORCID https://orcid.org/0000-0002-1111-966X
Catherine CargoHaematological Malignancy Diagnostic Service, Leeds Cancer Centre St James's University Hospital & Leeds Teaching Hospitals NHS Trust Leeds UK.ORCID https://orcid.org/0000-0002-5185-0190
Howard OsterDepartment of Medicine and The Department of Hematology Tel Aviv Sourasky (Ichilov) Medical Center and Medical Faculty Tel Aviv University Tel Aviv Israel.ORCID https://orcid.org/0000-0003-1936-4675
Argiris SymeonidisDepartment of Medicine Division of Hematology University of Patras Medical School Olympion Hospital & Rehabilitation Center Patras Greece.ORCID https://orcid.org/0000-0002-3685-3473
Reinhard StauderDepartment of Internal Medicine V (Haematology and Oncology) Innsbruck Medical University Innsbruck Austria.ORCID https://orcid.org/0000-0002-8993-9561
Saskia LangemeijerDepartment of Hematology Radboud University Medical Center Nijmegen The Netherlands.ORCID https://orcid.org/0000-0002-0366-0800
Luca MalcovatiDepartment of Hematology Oncology Fondazione IRCCS Policlinico San Matteo University of Pavia Pavia Italy.ORCID https://orcid.org/0000-0002-1460-1611
Pierre FenauxService d'Hématologie, Hôpital Saint-Louis Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7 Paris France.ORCID https://orcid.org/0000-0002-0468-3553
Jaroslav ČermákDepartment of Clinical Hematology Institute of Hematology & Blood Transfusion Praha Czech Republic.ORCID https://orcid.org/0009-0006-0961-3294
Eva Hellström-LindbergDepartment of Medicine Division Hematology Center For Hematology and Regenerative Medicine Karolinska Institutet Stockholm Sweden.ORCID https://orcid.org/0000-0002-7839-3743
Juliet MillsDepartment of Haematology Worcestershire Acute Hospitals NHS Trust and University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Ioannis KotsianidisDepartment of Hematology University Hospital of Alexandroupolis Democritus University of Thrace Medical School Alexandroupolis Greece.ORCID https://orcid.org/0000-0001-7668-0186
Maud D'AveniHematology Department CHRU-Nancy Université De Lorraine Nancy France.ORCID https://orcid.org/0000-0002-5909-2742
Corine van MarrewijkDepartment of Hematology Radboud University Medical Center Nijmegen The Netherlands.ORCID https://orcid.org/0000-0002-9547-908X
Marlijn HoeksDepartment of Hematology Radboud University Medical Center Nijmegen The Netherlands.ORCID https://orcid.org/0000-0003-3136-3739
Theo de WitteDepartment of Tumor Immunology-Nijmegen Center for Molecular Life Sciences Radboud University Medical Center Nijmegen The Netherlands.ORCID https://orcid.org/0000-0001-5897-4287
David BowenSt. James's Institute of Oncology Leeds Teaching Hospitals Leeds UK.ORCID https://orcid.org/0000-0003-2294-2544
Moshe MittelmanDepartment of Medicine and The Department of Hematology Tel Aviv Sourasky (Ichilov) Medical Center and Medical Faculty Tel Aviv University Tel Aviv Israel.ORCID https://orcid.org/0000-0001-7677-9119

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ESA responseleukemia‐free survivalmyelodysplastic syndromesoverall survivalprognosisserum erythropoietin levelstransfusion free survival

Identifiers

PMID42529759
PMCPMC13418852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.